Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2

<p dir="ltr">Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms.</p><p dir="ltr">We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with p...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Elias Tayar (16488567) (author)
مؤلفون آخرون: Ryan Isber (16488573) (author), Nidal Isber (16488574) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513564208791552
author Elias Tayar (16488567)
author2 Ryan Isber (16488573)
Nidal Isber (16488574)
author2_role author
author
author_facet Elias Tayar (16488567)
Ryan Isber (16488573)
Nidal Isber (16488574)
author_role author
dc.creator.none.fl_str_mv Elias Tayar (16488567)
Ryan Isber (16488573)
Nidal Isber (16488574)
dc.date.none.fl_str_mv 2023-06-21T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.heliyon.2023.e17149
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Long_COVID_treated_successfully_with_antivirals_in_a_rituximab-treated_follicular_lymphoma_patient_with_persistent_negative-antibodies_to_SARS-CoV2/23622591
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
COVID-19
Antivirals
Follicular lymphoma
Long COVID
dc.title.none.fl_str_mv Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms.</p><p dir="ltr">We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive antiviral treatment.</p><h2>Other Information</h2><p dir="ltr">Published in: Heliyon<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1016/j.heliyon.2023.e17149" target="_blank">http://dx.doi.org/10.1016/j.heliyon.2023.e17149</a></p>
eu_rights_str_mv openAccess
id Manara2_2b9c4b1d199a887ddc4667c6a990bc3d
identifier_str_mv 10.1016/j.heliyon.2023.e17149
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/23622591
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2Elias Tayar (16488567)Ryan Isber (16488573)Nidal Isber (16488574)Biomedical and clinical sciencesCardiovascular medicine and haematologyOncology and carcinogenesisCOVID-19AntiviralsFollicular lymphomaLong COVID<p dir="ltr">Long COVID is a well-known complication to COVID-19 that affect millions of people worldwide and causes wide range of symptoms.</p><p dir="ltr">We present a rare case of a previously diagnosed follicular lymphoma patient, who had a long COVID with persistent negative SARS-CoV-2 antibodies and required an aggressive antiviral treatment.</p><h2>Other Information</h2><p dir="ltr">Published in: Heliyon<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1016/j.heliyon.2023.e17149" target="_blank">http://dx.doi.org/10.1016/j.heliyon.2023.e17149</a></p>2023-06-21T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.heliyon.2023.e17149https://figshare.com/articles/journal_contribution/Long_COVID_treated_successfully_with_antivirals_in_a_rituximab-treated_follicular_lymphoma_patient_with_persistent_negative-antibodies_to_SARS-CoV2/23622591CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/236225912023-06-21T00:00:00Z
spellingShingle Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
Elias Tayar (16488567)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
COVID-19
Antivirals
Follicular lymphoma
Long COVID
status_str publishedVersion
title Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_full Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_fullStr Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_full_unstemmed Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_short Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
title_sort Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
COVID-19
Antivirals
Follicular lymphoma
Long COVID